tenk.fyi

Roivant Sciences Ltd.

ROIVNasdaq· Pharmaceutical Preparations

Price History

Revenue

$29.1M

11.2% YoY

Net Income

-$172.0M

104.0% YoY

EPS

$-0.24

104.6% YoY

Cash

$2.7B

58.2% YoY

FY 2025 · As of 2025-03-31

No recent insider transactions found.

ProShowing last 90 days. Full 12+ month history available on Pro.
Upgrade